code | marketCap | change | rps50 | rps120 | rps250 | industry | sectors |
---|---|---|---|---|---|---|---|
Accuray ARAY | 183.04M | -0.56% | 28 | 51 | 35 | Medical Devices | Cancer Research |
Biogen BIIB | 19.33B | -3.52% | 54 | 25 | 26 | Drug Manufacturers - General | Cancer Research |
121.17B | -2.36% | 82 | 80 | 75 | Drug Manufacturers - General | Cancer Research | |
5.49B | -2.90% | 35 | 57 | 46 | Biotechnology | Cancer Research | |
Exact Sciences EXAS | 8.07B | +0.37% | 40 | 19 | 26 | Diagnostics & Research | ARK Portfolio;Cancer Research;AI medical concept stocks |
Gilead Sciences GILD | 138.73B | -0.69% | 95 | 92 | 93 | Drug Manufacturers - General | CAR-T Therapy;Cancer Research;Infectious Disease;Mpox (monkeypox) |
Merck & Co MRK | 220.07B | -2.94% | 42 | 34 | 31 | Drug Manufacturers - General | ESG Investing;Cancer Research;Infectious Disease |
Novartis AG NVS | 216.49B | -1.68% | 93 | 62 | 76 | Drug Manufacturers - General | CAR-T Therapy;Cancer Research |
Pfizer PFE | 139.18B | -3.16% | 56 | 44 | 50 | Drug Manufacturers - General | CAR-T Therapy;Cancer Research;Weight Loss Drugs;Infectious Disease |